1. P01.098 Have we been still defeated with treatment of GBM IDH wild-type recurrency. (19th September 2018) Authors: Kalita, O; Vaverka, M; Hrabalek, L; Vrana, D; Trojanec, R; Sporikova, Z; Hajduch, M; Drabek, J; Hok, P; Hlustik, P; Tuckova, L; Vrbkova, J Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii253 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P09.05 Treatment strategy of MRI postcontrast non-enhanced gliomas. (9th September 2021) Authors: Kalita, O; Hrabalek, L; Jan, V; Slachta, M; Klementová, Y; Dolezel, M; Cechakova, E; Drabek, J; Hajduch, M; Hok, P; Hlustik, P; Tuckova, L; Halaj, M; Vrbkova, J Journal: Neuro-oncology Issue: Volume 23: Supplement 2 (2021) Page Start: ii27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P14.68 Life expectancy in biopsied GBM patients: a single-centre experience. (6th September 2019) Authors: Kalita, O; Sporikova, Z; Halaj, M; Cwiertka, K; Vaverka, M; Hrabalek, L; Trojanec, R; Hajduch, M; Drabek, J; Vrbkova, J Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 3 Page Start: iii83 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗